Medline Inc (MDLN)

Currency in USD
45.32
+1.13(+2.56%)
Closed·
45.25-0.07(-0.15%)
·
Earnings results expected tomorrow
MDLN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
43.5345.67
52 wk Range
34.8950.88
Key Statistics
Prev. Close
44.19
Open
44.19
Day's Range
43.53-45.67
52 wk Range
34.89-50.88
Volume
3.68M
Average Volume (3m)
5.91M
1-Year Change
-
Book Value / Share
12.9
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MDLN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
53.52
Upside
+18.09%
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Healthcare Equipment & Supplies industry

Medline Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

23 Buy
5 Hold
0 Sell
Ratings:
28 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 53.52
(+18.09% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Baird
Buy57.00+25.77%56.00Maintain19/03/2026
Citi
Buy60.00+32.39%-New Coverage11/03/2026
JPMorgan
Buy53.00+16.95%50.00Maintain10/03/2026
Tigress Financial Partners
Buy60.00+32.39%-Maintain09/03/2026
BTIG
Buy55.00+21.36%-Maintain09/03/2026

Medline Inc Earnings Call Summary for Q4/2025

  • Q4 net sales surged 15% YoY to $7.8B, but adjusted EBITDA flat at $805M with margins down 160 bps; stock fell 2.91% to $47.11 pre-market
  • Full-year 2025 free cash flow reached $1.3B; capex of $447M directed toward automation investments and distribution center expansion
  • Tariff mitigation delivered $35M favorable variance in 2025, but company faces projected $200M incremental tariff headwinds in 2026
  • FY2026 guidance projects revenue of $30.57B and EPS of $2.38, supported by continued investments in automation and product innovation
  • Stock trades at elevated P/E of 558x with $67.3B market cap; InvestingPro rates financial health as 'GREAT' despite overvaluation concerns
Last Updated: 25/02/2026, 15:48
Read Full Transcript

Earnings

Latest Release
25/02/2026
EPS / Forecast
-0.01 / --
Revenue / Forecast
7.79B / --
EPS Revisions
Last 90 days

Compare MDLN to Peers and Sector

Metrics to compare
MDLN
Peers
Sector
Relationship
P/E Ratio
32.8x−10.7x−0.5x
PEG Ratio
0.027.830.00
Price/Book
5.5x6.1x2.6x
Price / LTM Sales
2.1x0.0x3.3x
Upside (Analyst Target)
24.3%177.8%47.1%
Fair Value Upside
Unlock−21.7%6.2%Unlock

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon’s gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
125.49M14.84%5.55B
Other Institutional Investors
743.62M85.16%32.86B
Public Companies & Retail Investors
0.000.00%0.00
Total
869.1M100.00%38.41B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
The Carlyle Group Inc.14.84%125,454,2415,543,823
Blackstone Inc.14.69%124,198,3485,488,325

People Also Watch

28.41
CRBG
+4.93%
98.77
LGN
+8.05%
44.12
ESI
+3.08%
168.19
ECG
+11.44%

FAQ

What Is the Medline (NASDAQ: MDLN) Share Price Today?

The Medline stock price today is 45.32 USD.

What Stock Exchange Does Medline (MDLN) Trade On?

Medline is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Medline?

The stock symbol (also called a 'ticker') for Medline is "MDLN."

What Is the Current Medline Market Capitalisation?

As of today, Medline (NASDAQ: MDLN) market cap is 58.05B USD.

What Is Medline's (MDLN) Earnings Per Share (TTM)?

The Medline EPS is currently 1.43 (Trailing Twelve Months).

When Is the Next Medline Earnings Date?

Medline's next earnings report will be released on 06/05/2026.

Is MDLN a Buy or Sell From a Technical Analyst Perspective?

Based on today's Medline moving averages and other technical indicators, the daily buy/sell signal for MDLN stock is Neutral.

How Many Times Has Medline Stock Split?

Medline has split 0 times. (See the MDLN stock split history page for full effective split date and price information.)

How Many Employees Does Medline Have?

Medline has 45000 employees, based on their latest Companies House report.

What is the current trading status of Medline (NASDAQ: MDLN)?

As of 05/05/2026, Medline (MDLN) is trading at a share price of 45.32 USD, with a previous close of 44.19 USD. The stock has fluctuated within a day range of 43.53 USD to 45.67 USD, while its 52-week range spans from 34.89 USD to 50.88 USD.

What Is Medline (MDLN) Price Target According to Analysts?

The average 12-month price target for Medline is 53.52 USD, with a high estimate of 60 USD and a low estimate of 45 USD. 23 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +18.09% Upside potential.

What Is the MDLN Premarket Price?

MDLN's last pre-market stock price is 43.75 USD. The pre-market share volume is 120.00, and the stock has decreased by -0.44, or -1.00%.

What Is the MDLN After Hours Price?

MDLN's last after hours stock price is 45.25 USD, the stock has decreased by -0.07, or -0.15%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.